Document 0627 DOCN M9490627 TI An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase. DT 9411 AU Evans DB; Fan N; Swaney SM; Tarpley WG; Sharma SK; Biochemistry Research, Upjohn Laboratories, Kalamazoo, Michigan; 49001. SO J Biol Chem. 1994 Aug 26;269(34):21741-7. Unique Identifier : AIDSLINE MED/94342369 AB An active p15 RNase H domain, consisting of amino acids 427-560 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and a genetically engineered penta-histidine N-terminal affinity tag, was expressed in Escherichia coli and purified to apparent homogeneity by immobilized metal affinity chromatography. The purified p15 RNase H domain exhibited no substrate preference for [3H]poly(rG).poly(dC) compared to [3H]poly(rA).poly(dT), in contrast with the HIV-1 RT-associated RNase H, which showed a 30-fold preference for the former substrate. Unlike the HIV-1 RT-associated RNase H, when challenged with unlabeled substrate, the recombinant p15 RNase H domain was relatively nonprocessive in RNA degradative activity of the [3H]poly(rA).poly(dT) duplex. Kinetic studies using p15 RNase H showed substrate inhibition with an apparent K(i) value of 0.12 micron for the [3H]poly(rA).poly(dT) hybrid. Substrate inhibition was not observed for the HIV-1 RT-associated RNase H. The results show that the isolated p15 HIV-1 RNase H domain is functionally distinct from the recombinant HIV-1 RT-associated RNase H. DE Amino Acid Sequence Base Sequence Cations, Divalent/PHARMACOLOGY Comparative Study Escherichia coli/GENETICS HIV-1/*ENZYMOLOGY Molecular Sequence Data Peptide Fragments/GENETICS/*METABOLISM Protein Engineering Recombinant Proteins/METABOLISM Reverse Transcriptase/ANTAGONISTS & INHIB/DRUG EFFECTS/GENETICS/ *METABOLISM Ribonuclease H, Calf Thymus/DRUG EFFECTS/GENETICS/*METABOLISM RNA/METABOLISM Substrate Specificity Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).